Effect of NMES on Spasticity
ConditionPost-Stroke Spasticity
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorIzmir Katip Celebi University
About this trial
The goal of this clinical trial is to learn if neuromuscular electrical stimulation (NMES) works to treat spasticity in adult patients with spasticity related to stroke. The main question it aims to answer is:
• Does NMES reduces the severity of spasticity? Researchers will compare NMES treatment to baseline and non-stimulation periods to see if NMES works to treat spasticity.
Participants will:
• first undergo an initial assessment at 10-minute intervals for one hour, followed by 20 minutes of NMES exposure, and subsequent post-treatment assessments at 10-minute intervals for two hours. This daily procedure will be repeated over four days for one patient, and performed only once for the remaining three patients.
Eligibility criteria
Qualifiers
Age between 18 and 70 years
Post-stroke wrist flexor spasticity scored as Grade 2 or 3 on the Australian Spasticity Assessment Scale (ASAS), specifically selecting patients whose passive stretch resistance (post-catch response) can be easily overcome to ensure accurate and unconfounded electrophysiological evaluation.
Provision of voluntary, written informed consent prior to study enrollment.
Disqualifiers
Age <18 or >70 year
Contraindications to neuromuscular electrical stimulation (e.g., active electronic implants, history of epilepsy, or localized skin lesions preventing electrode placement)
Concomitant wrist contracture or pain sufficient to impede clinical evaluation
Structural abnormalities of the elbow joint obstructing median nerve stimulation
Trial design
Treatments tested in this trial
- Neuromuscular electrical stimulation (NMES)
- Neuromuscular electrical stimulation (NMES)
Treatment groups
4 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov